Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SYP | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
mRNA | SHC2 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
mRNA | SLC26A5 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
mRNA | FAM171A2 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-08 |
mRNA | SEPT3 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
mRNA | NCAN | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
mRNA | ZNF177 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
mRNA | CCP110 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
mRNA | RUFY3 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
mRNA | PEX5L | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |